In a world-first, researchers have developed a drug that targets both critical regions of the tau protein, a key factor in Alzheimer's disease. The study, published in Alzheimer's & Dementia, has ...

Scientists are exploring many ways to tackle tau pathology. In the October 17 Cell Chemical Biology, researchers led by Jian-Zhi Wang at the Huazhong University of Science and Technology, Wuhan, China ...

The study found that the medication, called RI-AG03, was effective at preventing the build-up of Tau proteins in both laboratory and fruit fly studies. Lead author Dr Anthony Aggidis, former ...

For the first time, scientists have developed a drug that works on both major aggregation-promoting ‘hotspots’ of the Tau protein in the brain - a key driver of neurodegeneration. The drug ...

The drug - called RI-AG03 - targets spots in the brain that promote the abnormal buildup of tau, a protein that forms "tangles" around cells and is a key driver in the decline of brain function.

The study found that the medication, called RI-AG03, was effective at preventing the buildup of Tau proteins in both laboratory and fruit fly studies. Lead author Dr Anthony Aggidis, a former ...

In fruit fly models and lab experiments on human-derived cells, the team demonstrated that RI-AG03 was effective at preventing the harmful clumping of tau proteins—which is linked to ...